Clinical trial
A Drug-drug Interaction Study to Evaluate the Effect of Rifampicin and Cyclosporine on the Pharmacokinetics of Methotrexate in Healthy Subjects
NCT07196449 is registered in ClinicalTrials.gov with Seoul National University Bundang Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Drug-drug Interaction Study to Evaluate the Effect of Rifampicin and Cyclosporine on the Pharmacokinetics of Methotrexate in Healthy Subjects
- Lead sponsor
- Seoul National University Bundang Hospital
- Phase
- Phase 1
- Overall status
- Active, not recruiting
- Start date
- May 14, 2025
- Completion date
- April 14, 2026
- Enrollment
- 12 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
drug drug interaction (ddi)